AAAAAA

   
Results: 1-12 |
Results: 12
Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer
Authors: Jonkers, J Meuwissen, R van der Gulden, H Peterse, H van der Valk, M Berns, A
Citation: J. Jonkers et al., Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer, NAT GENET, 29(4), 2001, pp. 418-425
Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene
Authors: Meuwissen, R Linn, SC van der Valk, M Mooi, WJ Berns, A
Citation: R. Meuwissen et al., Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene, ONCOGENE, 20(45), 2001, pp. 6551-6558
Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection
Authors: van der Valk, M Gisolf, EH Reiss, P Wit, FWNM Japour, A Weverling, GJ Danner, SA
Citation: M. Van Der Valk et al., Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection, AIDS, 15(7), 2001, pp. 847-855
Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways
Authors: van der Valk, M Bisschop, PH Romijn, JA Ackermans, MT Lange, JMA Endert, E Reiss, P Sauerwein, HP
Citation: M. Van Der Valk et al., Lipodystrophy in HIV-1-positive patients is associated with insulin resistance in multiple metabolic pathways, AIDS, 15(16), 2001, pp. 2093-2100
Conditional biallelic Nf2 mutation in the mouse promotes manifestations ofhuman neurofibromatosis type 2
Authors: Giovannini, M Robanus-Maandag, E van der Valk, M Niwa-Kawakita, M Abramowski, V Goutebroze, L Woodruff, JM Berns, A Thomas, G
Citation: M. Giovannini et al., Conditional biallelic Nf2 mutation in the mouse promotes manifestations ofhuman neurofibromatosis type 2, GENE DEV, 14(13), 2000, pp. 1617-1630
Acceleration of lymphomagenesis in mismatch-repair deficient mice by exposure to genotoxic agents
Authors: Jansen, L Claij, N Dekker, M van Klink, Y van der Valk, M van't Wout, K Riele, HT
Citation: L. Jansen et al., Acceleration of lymphomagenesis in mismatch-repair deficient mice by exposure to genotoxic agents, TOX LETT, 112, 2000, pp. 245-250
Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier
Authors: Wijnholds, J de Lange, ECM Scheffer, GL van den Berg, DJ Mol, CAAM van der Valk, M Schinkel, AH Scheper, RJ Breimer, DD Borst, P
Citation: J. Wijnholds et al., Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier, J CLIN INV, 105(3), 2000, pp. 279-285
HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3and MSh6 mismatch-repair protein functions
Authors: de Wind, N Dekker, M Claij, N Jansen, L van Klink, Y Radman, M Riggins, G van der Valk, M van 't Wout, K Riele, HT
Citation: N. De Wind et al., HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3and MSh6 mismatch-repair protein functions, NAT GENET, 23(3), 1999, pp. 359-362
Overexpression of Frat1 in transgenic mice leads to glomerulosclerosis andnephrotic syndrome, and provides direct evidence for the involvement of Frat1 in lymphoma progression
Authors: Jonkers, J Weening, JJ van der Valk, M Bobeldijk, R Berns, A
Citation: J. Jonkers et al., Overexpression of Frat1 in transgenic mice leads to glomerulosclerosis andnephrotic syndrome, and provides direct evidence for the involvement of Frat1 in lymphoma progression, ONCOGENE, 18(44), 1999, pp. 5982-5990
In vivo analysis of Frat1 deficiency suggests compensatory activity of Frat3
Authors: Jonkers, J van Amerongen, R van der Valk, M Robanus-Maandag, E Molenaar, M Destree, O Berns, A
Citation: J. Jonkers et al., In vivo analysis of Frat1 deficiency suggests compensatory activity of Frat3, MECH DEVEL, 88(2), 1999, pp. 183-194
Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein
Authors: Giovannini, M Robanus-Maandag, E Niwa-Kawakita, M van der Valk, M Woodruff, JM Goutebroze, L Merel, P Berns, A Thomas, G
Citation: M. Giovannini et al., Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein, GENE DEV, 13(8), 1999, pp. 978-986
Partial rescue of epithelial phenotype in integrin beta 4 null mice by a keratin-5 promoter driven human integrin beta 4 transgene
Authors: van der Neut, R Cachaco, AS Thorsteinsdottir, S Janssen, H Prins, D Bulthuis, J van der Valk, M Calafat, J Sonnenberg, A
Citation: R. Van Der Neut et al., Partial rescue of epithelial phenotype in integrin beta 4 null mice by a keratin-5 promoter driven human integrin beta 4 transgene, J CELL SCI, 112(22), 1999, pp. 3911-3922
Risultati: 1-12 |